News
Utformning av klinisk studie påbörjas
Eurocine Vaccines har inlett arbetet med att utforma den kliniska studien med vaccinkandidaten mot klamydia, planerad att starta hösten 2022.Read More
Interviews with CEO Hans Arwidsson
Eurocine Vaccines AB has published two interviews with CEO Hans Arwidsson in connection with the ongoing preferential issue of units. The interviews, which have partly…
Intervjuer med VD Hans Arwidsson
Eurocine Vaccines AB har offentliggjort två intervjuer med VD Hans Arwidsson med anledning av den pågående företrädesemissionen av units. Intervjuerna, som har delvis olika innehåll,…
Calendar
Subscription period in Eurocine Vaccines´ unit issue
For more information about the unit issue and to download the prospectus (in Swedish), please see Investors !Read More
BioTrinity 2021
BioTrinity is a highly regarded biopartnering & investment life sciences conference, that aims to shine a light on new innovation in the life sciences industry andRead…
Biotech Outsourcing Strategies (BOS) Virtual
Eurocine Vaccines has been invited to present at BOS R&D Outsourcing Week together with Biovian Oy, Turku, Finland. In the presentation, Eurocine Vaccines will describeRead…